Indomethacin and patent ductus arteriosus: effects on renal function in preterm lambs.
To examine the independent effects of a patent ductus arteriosus and of indomethacin therapy on the renal function of the preterm newborn, we created a preterm lamb model in which ductus diameter could be regulated. We studied 24 preterm newborn lambs. Eight lambs (group 1) had their ductus closed at delivery and received no indomethacin. Eight lambs (group 2) had their ductus closed and then received indomethacin (0.3 mg/kg) at 5.5 h; eight lambs (group 3) had their ductus kept open and then received indomethacin at 5.5 h. Hemodynamic and renal function measurements were made at 5 h (pretreatment) and at 12.5 h. In group 2 lambs there was a significant reduction in inulin clearance (GFR) and osmolal clearance after indomethacin. In contrast, lambs with an open ductus (group 3), when compared with lambs with a closed ductus (groups 1 and 2) at 5 h, already had significantly decreased blood pressure, GFR, urine volume, and osmolal clearance. Following indomethacin treatment, group 3 lambs showed no further decrease in renal function. We suggest that in preterm lambs with patent ductus, the apparent lack of renal dysfunction following indomethacin treatment reflects underlying diminished renal function.
Gleason
C A
CA
Cardiovascular Research Institute, University of California, San Francisco 94143.
Clyman
R I
RI
Heymann
M A
MA
Mauray
F
F
Leake
R
R
Roman
C
C
D000818:Animals; D001127:Arginine Vasopressin / Q000097:blood; D015232:Dinoprostone; D004374:Ductus Arteriosus, Patent / Q000503:physiopathology*; D005333:Fetus / Q000502:physiology; D005865:Gestational Age; D005919:Glomerular Filtration Rate; D007213:Indomethacin / Q000494:pharmacology*; D007668:Kidney / Q000503:physiopathology*; D011458:Prostaglandins E / Q000097:blood; D012039:Regional Blood Flow; D012083:Renin / Q000097:blood; D012756:Sheep
D011458:Prostaglandins E; D001127:Arginine Vasopressin; D012083:Renin; D015232:Dinoprostone; D007213:Indomethacin